LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

7.5.2026 10:00:00 EEST | Business Wire | Press release

LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506065669/en/

Bernard Blerot, VP R&D Naturals at IFF, smelling geranium in a botanical research laboratory.

“Responsible innovation has always been central to LMR,” said Bertrand de Préville, general manager of LMR. “Our strength lies in our ability to master the full range of natural technologies to support perfumers’ creativity. We’re connecting nature, science and creation to drive sustainable growth and deliver added value to our customers at global scale.”

Four New LMR Hearts Introduced at SIMPPAR
LMR Naturals’ new LMR Hearts, each developed through long‑term sourcing partnerships, sustainable agricultural practices and precision molecular distillation andfractionation at LMR’s Grasse site include:

Lavandin Heart France, withastrong coumarin profile for a more gourmand note
Armoise Heart Morocco, which isricher in thujones for a fresher, more diffusive impact
Ylang Heart Madagascar, offeringa unique “extra grade”, creamy and solar olfactive profile
Geranium Heart Egypt, featuring a fruity-lychee profile without conventional minty aspects

“These new Hearts illustrate how science and sourcing expertise can elevate natural ingredients,” said Bernard Blerot, VP R&D Naturals at IFF. “They provide greater purity and focus while maintaining the integrity of the natural material and demonstrate our team’s scientific stewardship.”

Natural Ingredients Innovation
The four LMR Hearts launched at SIMPPAR follow several natural ingredient innovations introduced earlier this year, including:

Tonka Bean CO₂ Absolute, produced using renewable supercritical CO₂ extraction at LMR’s Aumont‑Aubrac facility in France
Osmanthus Absolute Fruity China, a fruit‑forward interpretation developed as a captive natural for IFF perfumers
Pulpextract™ Passion Fruit and Raspberry, two new fruit ingredients offering vivid, juicy profiles exclusively for IFF perfumers

Each new natural ingredient responds to sustained consumer interest in fruity and gourmand fragrance notes, which IFF insights show make up a significant and enduring share of women’s fragrances. LMR strives to continuously expand the perfumer’s palette with naturals that combine innovation, sustainability and olfactive expression.

These launches support IFF’s 25‑year investment in LMR and sustainable, natural materials, embedding pioneering science — from seed and cultivation to harvesting and extraction — in perfumers' creativity at scale. In late May, IFF will further strengthen this integrated ecosystem with the inauguration of the Domaine des Naturals LMR in Grasse, a dedicated experimental field for raw materials that underscores its long‑term commitment to the future of naturals and innovation.

LMR Naturals’ integrated natural ingredients platform combines long‑term sourcing partnerships, agronomy‑led sustainability programs and internally operated extraction technologies — including molecular distillation, fractionation, CO₂ extraction and more. By operating these technologies on its own sites, LMR Naturals and its internal team of experts can focus on the most desirable olfactive molecules as selected by perfumers. With this approach, LMR Naturals delivers traceable, sustainable and performance‑driven natural ingredients for fine fragrance and other applications.

About LMR Naturals by IFF
Founded in 1983 by Monique Rémy and acquired by IFF in 2000, LMR Naturals is a trademarked capability within IFF dedicated to the development of high‑quality, innovative and sustainably sourced natural ingredients. LMR Naturals supports perfumers worldwide with a broad portfolio of naturals across fine fragrance, beauty, personal care, home care and flavorists with taste applications.

For more information, visit https://www.iff.com/scent/lmr-naturals/.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506065669/en/

Contacts

Judith Gross, VP, Communications & Branding
Department: Scent
Email: scentmediarequest@iff.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MOVIVA ® launch spotlight at ESGE Days 20267.5.2026 10:58:00 EEST | Press release

During its 175th anniversary year, Erbe Elektromedizin GmbH highlights its continued commitment to healthcare innovation with the launch of MOVIVA®, a minimally invasive solution for gastric mucosal ablation (GMA) in endoscopic obesity therapy. MOVIVA® will be the central focus of Erbe’s activities at ESGE Days in Milan, 14–16 May 2026. Physicians can explore the technology in the hands-on area and attend a dedicated symposium. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507842222/en/ How GMA with MOVIVA® works “Obesity continues to rise worldwide, and many patients still face a gap between lifestyle interventions, pharmacotherapy, and bariatric surgery. Endoscopic approaches are emerging as additional treatment options. With MOVIVA®, we aim to support physicians in bringing this innovative treatment option into clinical practice and expanding access to minimally invasive obesity therapies.” Marcus Felstead, Chief Comm

Resilience Takes Center Stage as Europe’s LEED Community Gathers in Milan for GBCI Europe Circle 20267.5.2026 10:57:00 EEST | Press release

Green Business Certification Inc. Europe (GBCI), is hosting Circle 2026, the annual flagship event of the European LEED community, taking place in Milan from May 6–8 and marking its fifth anniversary. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506692329/en/ Porta Nuova, Milan - LEED v4.1 Communities: Existing, Gold certification. Photo courtesy of COIMA. At the center of discussions is LEED v5, the latest version of the world’s most widely used green building rating system, as a bridge to EU Taxonomy alignment - a critical priority for the European market, where regulatory pressure and investor demand are accelerating the integration of certification, finance, and ESG reporting. GBCI Europe Impact Report 2026: European Real Estate Shifts from Sustainability to Risk Management As part of the main conference program, Peter Templeton, President and CEO of USGBC and GBCI will present the GBCI Europe Impact Report 2026, ba

Criteo Selects Navan to Modernize Global Travel Management7.5.2026 10:00:00 EEST | Press release

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that it has been selected by Criteo, the global commerce intelligence platform, to modernize its global travel program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507251188/en/ Global commerce intelligence platform delivers high employee satisfaction with Navan Criteo set out to provide its global workforce with an easy-to-use travel booking experience that brought visibility and control to its travel spending. Prioritizing operational excellence and employee experience, Criteo selected Navan because of its extensive inventory, unified travel and payments platform, and global expertise in sustainability reporting. “We wanted to give our teams a travel tool that’s as easy to use as the apps they use in their personal lives,” said Sarah Glickman, Chief Financial Officer at Criteo. “Our goal with Navan was to improve the use

Apis Partners Announces Final Close of $1.23 Billion Fund III, Double its Predecessor7.5.2026 09:00:00 EEST | Press release

Apis Partners Group (UK) Limited (“Apis”), a private equity firm investing in tech-enabled businesses in financial infrastructure and services, today announced the final close of Apis Global Growth Fund III and Apis Growth Markets Fund III (the “Funds” or “Fund III”), with combined commitments of $1.23 billion excluding co-investments, more than double its predecessor, Apis Growth Fund II, at $563 million. The Funds closed 23% above target.Reflecting the strong performance of previous funds,which have already generated in excess of $1 billion in realisations to date, over 70% of existing LPs have re-upped and increased on their previous fund’s commitments, accounting for around 50% of the total capital raised in Fund III. The significant increase in fund size allowed Apis to welcome a number of new investors to its global institutional investor base, including sovereign and supranational investors alongside banks, insurers, pension funds, funds of funds and foundations. Fund III will b

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 20267.5.2026 08:13:00 EEST | Press release

A path breaking scientific discovery, unraveling successful wound healing mechanism in urethral stricture with BEES-HAUS cell therapy has been reported by Indo-Japan physician-scientists. This milestone achievement in regenerative medicine, yielding clinical safety and efficacy, is the first of its kind, wherein a hybrid approach of mixing two groups of autologous buccal epithelial cells,one cultured in 2D and another in 3D in Festigel scaffold were used in the management of urethral stricture; paracrine effect of IGF-1 produced by 2D-cultured cells and engraftment of 3D-Festigel cultured cells, which cover the urethrotomy wound, together repairing the urothelial defect, has been published in Frontiers in Urology. This feat though modest, is a global first in terms of both in vitro tissue engineering and clinical benefits by in vivo healing, restoring the urothelial integrity and is a giant leap for its potential of yielding stricture recurrence-free good quality of life to patients wi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom